Global

Immunoglobulins

About Our Therapies
Product List
Resources


This Global website is not intended to represent or suggest that particular products are approved or authorized in any particular jurisdiction. You should not construe anything on this website as a promotion or solicitation for any product or service, or as suggesting that a product or service be used where it is not approved or authorized by applicable law and regulation in a particular country, territory, or jurisdiction. To learn which products are approved or authorized in particular countries, please consult the appropriate country-specific website.

Treatment Area Product Name Generic Name Product Description
Replacement therapy in:
Primary immunodeficiency syndromes (more)

Congenital AIDS with recurrent bacterial infections

Cancer of bone marrow (myeloma)

Malignant illness of white blood cells (chronic lymphocytic leukaemia)

After allogenic haematopoietic stem cell transplantation
Privigen®

Carimune® NF, Sandoglobulin®, Redimune®, Sanglopor®
Human polyvalent immunoglobulin



Human normal immunoglobulins for intravenous (IV) administration
Liquid 10% solution for IV administration



Freeze-dried immunoglobulin formulations for IV administration
Immunomodulatory treatment in:
  • Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Multifocal motor neuropathy (MMN)
  • Myasthenia gravis (MG)
Sandoglobulin® Human normal immunoglobulins for intravenous (IV) administration Freeze-dried immunoglobulin formulations for IV administration
Immunomodulatory treatment in:
Immune Thrombocytic Purpura (ITP)
Guillain-Barré syndrome
Kawasaki disease
Privigen®

Carimune® NF, Sandoglobulin®, Redimune®, Sanglopor®
Human normal immunoglobulins for intravenous (IV) administration


Human polyvalent immunoglobulin
Liquid, ready-to-use 10% immunoglobulin solution for IV administration


Liquid 10% solution for IV administration
Replacement therapy for persons with:
  • Congenital (primary) immunodeficiency syndromes (more)
  • Cancer of bone marrow (myeloma)
  • Malignant illness of white blood cells (chronic lymphatic leukemia)
Hizentra® Human normal immunoglobulin Liquid, ready-to-use 20% solution for subcutaneous administration
Prevention of hemolytic disease of the newborn;
Immune thrombocytopenic purpura (ITP)
Rhophylac® Human anti-D immunoglobulin Prefilled syringes of highly purified anti-Rhesus factor D IgG for IV and intramuscular (IM) injection
Human cytomegalovirus   Human cytomegalovirus immunoglobulin Liquid ready-to-use 5% solution for IV infusion
Rabies Berirab® P Rabies immunoglobulin Liquid, ready-to-use solution for IM injection
Human hepatitis A Beriglobin® P Human hepatitis A immunoglobulin Liquid, ready-to-use 16% solution for IM injection
Human hepatitis B Hepatitis B immunoglobulin P Behring Human hepatitis B immunoglobulin Liquid, ready-to-use solution for IM injection
Human tetanus Tetagam® P Human tetanus immunoglobulin Liquid, ready-to-use solution for IM injection
Human varicella Varicellon® Human varicella immunoglobulin Liquid, ready-to-use solution for IM injection

 
Share
LinkedIn Twitter Facebook Google+